{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:27:03Z","timestamp":1792052823677,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"am","delay-in-days":212,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["02\/2020\/\u0110X"],"award-info":[{"award-number":["02\/2020\/\u0110X"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jmgm.2023.108535","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T07:29:25Z","timestamp":1685604565000},"page":"108535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Upgrading nirmatrelvir to inhibit SARS-CoV-2 Mpro via DeepFrag and free energy calculations"],"prefix":"10.1016","volume":"124","author":[{"given":"Nguyen Minh","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Hai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Quan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Dao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thanh","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van V.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong Tuan","family":"Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-1768","authenticated-orcid":false,"given":"Son Tung","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2023.108535_bib1","series-title":"Nat Med","article-title":"Coronavirus disease (COVID-19) outbreak","year":"2021"},{"key":"10.1016\/j.jmgm.2023.108535_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2023.108535_bib3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2023.108535_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2023.108535_bib5","unstructured":"COVID-19 Vaccines. FDA, FDA, 2021, Vol. 2021."},{"key":"10.1016\/j.jmgm.2023.108535_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2023.108535_bib7","first-page":"2021","article-title":"SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination","author":"Hoffmann","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmgm.2023.108535_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03471-w","article-title":"Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2023.108535_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmgm.2023.108535_bib10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmgm.2023.108535_bib11","doi-asserted-by":"crossref","first-page":"eabi6226","DOI":"10.1126\/science.abi6226","article-title":"Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity","author":"Gobeil","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2023.108535_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2023.108535_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2023.108535_bib14","doi-asserted-by":"crossref","first-page":"13686","DOI":"10.1039\/D1SC03628A","article-title":"Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding","volume":"12","author":"Chan","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jmgm.2023.108535_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc5332","article-title":"3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV\u2013infected mice","volume":"12","author":"Rathnayake","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmgm.2023.108535_bib16","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus peplication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2023.108535_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","article-title":"Conservation of substrate specificities among coronavirus main proteases","volume":"83","author":"Hegyi","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jmgm.2023.108535_bib18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2023.108535_bib19","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/acs.jmedchem.0c01140","article-title":"Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities","volume":"65","author":"Cannalire","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2023.108535_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17558-5","article-title":"Theaflavin 3-gallate inhibits the main protease (Mpro) of SARS-CoV-2 and reduces its count in vitro","volume":"12","author":"Chauhan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2023.108535_bib21","series-title":"FDA Authorizes First Oral Antiviral for Treatment of COVID-19","year":"2021"},{"key":"10.1016\/j.jmgm.2023.108535_bib22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/molecules26030674","article-title":"Computational determination of potential multiprotein targeting natural compounds for rational drug design against SARS-COV-2","volume":"26","author":"Muhseen","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2023.108535_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","article-title":"Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations","volume":"7","author":"Zhang","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jmgm.2023.108535_bib24","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1039\/D1CC03953A","article-title":"Computational simulations on the binding and reactivity of a nitrile inhibitor of the SARS-CoV-2 main protease","volume":"57","author":"Ramos-Guzm\u00e1n","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jmgm.2023.108535_bib25","doi-asserted-by":"crossref","first-page":"27381","DOI":"10.1073\/pnas.2010470117","article-title":"Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jmgm.2023.108535_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jcc.25139","article-title":"Using the fast fourier transform in binding free energy calculations","volume":"39","author":"Nguyen","year":"2018","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2023.108535_bib27","doi-asserted-by":"crossref","first-page":"17478","DOI":"10.1039\/D1RA02529E","article-title":"Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2","volume":"11","author":"Tam","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2023.108535_bib28","doi-asserted-by":"crossref","first-page":"29266","DOI":"10.1039\/D2CP04476E","article-title":"Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro via physics- and knowledge-based approaches","volume":"24","author":"Ngo","year":"2022","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmgm.2023.108535_bib29","doi-asserted-by":"crossref","DOI":"10.1063\/1.1999637","article-title":"Direct calculation of the binding free energies of FKBP ligands","volume":"123","author":"Fujitani","year":"2005","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2023.108535_bib30","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1063\/1.1740409","article-title":"High\u2010temperature equation of state by a perturbation method. I. Nonpolar gases","volume":"22","author":"Zwanzig","year":"1954","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2023.108535_bib31","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/jcc.24502","article-title":"Fast and accurate determination of the relative binding affinities of small compounds to HIV-1 protease using non-equilibrium work","volume":"37","author":"Ngo","year":"2016","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2023.108535_bib32","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1021\/acs.jcim.1c00159","article-title":"Benchmark of popular free energy approaches revealing the inhibitors binding to SARS-CoV-2 Mpro","volume":"61","author":"Ngo","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2023.108535_bib33","doi-asserted-by":"crossref","first-page":"31991","DOI":"10.1039\/D0RA06212J","article-title":"Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations","volume":"10","author":"Pham","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2023.108535_bib34","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1039\/D1SC00163A","article-title":"DeepFrag: a deep convolutional neural network for fragment-based lead optimization","volume":"12","author":"Green","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jmgm.2023.108535_bib35","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1021\/acs.jcim.1c00103","article-title":"DeepFrag: an open-source browser app for deep-learning lead optimization","volume":"61","author":"Green","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2023.108535_bib36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jcc.26130","article-title":"Oversampling free energy perturbation simulation in determination of the ligand-binding free energy","volume":"41","author":"Ngo","year":"2020","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2023.108535_bib37","series-title":"Crystal Structure of SARS-CoV-2 Main Protease in Complex with Protease Inhibitor PF-07321332","author":"Zhao","year":"2021"},{"key":"10.1016\/j.jmgm.2023.108535_bib38","doi-asserted-by":"crossref","first-page":"38495","DOI":"10.1039\/D1RA06534C","article-title":"Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations","volume":"11","author":"Tam","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2023.108535_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.jmgm.2023.108535_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/prot.24350","article-title":"Motional timescale predictions by molecular dynamics simulations: case study using proline and hydroxyproline sidechain dynamics","volume":"82","author":"Aliev","year":"2014","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.jmgm.2023.108535_bib41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2023.108535_bib42","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2023.108535_bib43","series-title":"AMBER 18","author":"Case","year":"2018"},{"key":"10.1016\/j.jmgm.2023.108535_bib44","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1063\/1.1651473","article-title":"Calculating potentials of mean force from steered molecular dynamics simulations","volume":"120","author":"Park","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2023.108535_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9991(76)90078-4","article-title":"Efficient estimation of free energy differences from Monte Carlo data","volume":"22","author":"Bennett","year":"1976","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.jmgm.2023.108535_bib46","unstructured":"Chemicalize Was Used for Prediction of Chemical Properties."},{"key":"10.1016\/j.jmgm.2023.108535_bib47","series-title":"Schr\u00f6dinger Release 2020-4","author":"Schr\u00f6dinger Llc","year":"2020"},{"key":"10.1016\/j.jmgm.2023.108535_bib48","series-title":"The PreADME Approach: Web-Based Program for Rapid Prediction of Physico-Chemical, Drug Absorption and Drug-like Properties, EuroQSAR 2002 Designing Drugs and Crop Protectants: Processes, Problems and Solutions","first-page":"418","author":"Lee","year":"2003"},{"key":"10.1016\/j.jmgm.2023.108535_bib49","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen Dafydd","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2023.108535_bib50","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/asia.201900717","article-title":"The nature of hydrogen bonds: a delineation of the role of different energy components on hydrogen bond strengths and lengths","volume":"14","author":"van der Lubbe","year":"2019","journal-title":"Chem. Asian J."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632300133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332632300133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:12:57Z","timestamp":1761081177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332632300133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"alternative-id":["S109332632300133X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2023.108535","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upgrading nirmatrelvir to inhibit SARS-CoV-2 Mpro via DeepFrag and free energy calculations","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2023.108535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108535"}}